| Study title | A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects with Nonalcoholic Steatohepatitis and Fibrosis |
| Disease or condition | NASH-Nonalcoholic Steatohepatitis |
| Study type | Interventional (Clinical Trial) |
| Intervention/treatment | Saroglitazar Magnesium or Placebo |
| Phase | 2b |
| Study site | Carolinas Medical Center, Center for Liver Disease and Transplant (Atrium Health) |
| Study location | Charlotte, NC |
| Principal investigator name and email | Andrew deLemos, andrew.delemos@atriumhealth.org |
| Study coordinator name and email | Marina Sycheva, marina.sycheva@atriumhealth.org |
| Phone Contact | 704-446-4835 |
| Clinicaltrials.gov link | https://clinicaltrials.gov/ct2/show/NCT05011305 |